CELU
Celularity Inc Ordinary Shares - Class A
North American company
Right Arrow 1
Healthcare
Right Arrow 2
Biotechnology
Prev. Close
/
Mkt. Open
- / -
Volume
-
52w Low / High
- / -
Market Cap
-
P/E Ratio
-
Div. Yield
-
Bid
-
Ask
-
Last Traded
-
Chg
-
-
XNAS
-
Updated: -
Research
News & analysis
Loading...
Times are shown in GMT-4, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
Prev. Close
/
Mkt. Open
- / -
Volume
-
52w Low / High
- / -
Market Cap
-
P/E Ratio
-
Div. Yield
-
Company Profile
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.
Symbol
NASDAQ:CELU
ISIN
US1511901050
Currency
USD
Loading...
Loading Comparison
Latest CELU News